RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CAMERINI A
Collezione AO Ordine Mauriziano

Items : 8

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11.

2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Salerno F; Camerini A; Carta A; Follador A; Berardi R; Toschi L; Zoratto F; Cortinovis DL; Citarella F; Bulotta A; Rastelli F; Adamo V; Guida A; Manzo A; Cecere FL; Belluomini L; Roca E; Pasello G; Cerea G; Montrone M; Delcuratolo MD; Passiglia F; Guaitoli G; Bertolini F; Genova C; Caliman E; Mazzoni F; Siringo M; Gelibter A; et alii...

Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis. in iScience / iScience. 2023 Sep 22;26(11):107970. doi: 10.1016/j.isci.2023.107970. eCollection 2023 Nov 17.

2023
AO Ordine Mauriziano

Anpalakhan S; Signori A; Cortellini A; Verzoni E; Giusti R; Aprile G; Ermacora P; Catino A; Pipitone S; Di Napoli M; Scotti V; Mazzoni F; Guglielmini PF; Veccia A; Maruzzo M; Schinzari G; Casadei C; Grossi F; Rizzo M; Montesarchio V; Verderame F; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Tondini CA; Camerini A; Banzi MC; et alii...

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study. in EClinicalMedicine / EClinicalMedicine. 2023 Jun 29;61:102044. doi: 10.1016/j.eclinm.2023.102044. eCollection 2023 Jul.

2023
AO Ordine Mauriziano

Bersanelli M; Verzoni E; Cortellini A; Giusti R; Calvetti L; Ermacora P; Di Napoli M; Catino A; Guadalupi V; Guaitoli G; Scotti V; Mazzoni F; Veccia A; Guglielmini PF; Perrone F; Maruzzo M; Rossi E; Casadei C; Montesarchio V; Grossi F; Rizzo M; Travagliato Liboria MG; Mencoboni M; Zustovich F; Fratino L; Accettura C; Cinieri S; Camerini A; Sorarù M; et alii...

Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey. in Frontiers in cardiovascular medicine / Front Cardiovasc Med. 2022 May 10;9:920605. doi: 10.3389/fcvm.2022.920605. eCollection 2022.

2022
AO Ordine Mauriziano

Canale ML; Turazza F; Lestuzzi C; Parrini I; Camerini A; Russo G; Colivicchi F; Gabrielli D; Gulizia MM; Oliva S; Tarantini L; Maurea N; Rigacci L; Petrolati S; Casolo G; Bisceglia I;

Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey. in Frontiers in cardiovascular medicine / Front Cardiovasc Med. 2021 Jun 16;8:677544. doi: 10.3389/fcvm.2021.677544. eCollection 2021.

2021
AO Ordine Mauriziano

Petrolati S; Rigacci L; Maurea N; Tarantini L; Oliva S; Gulizia MM; Gabrielli D; Colivicchi F; Russo G; Camerini A; Parrini I; Lestuzzi C; Turazza F; Canale ML; Casolo G; Bisceglia I;

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baldessari C; Novello S; Bartoli G; Pizzutilo EG; Landi L; Dall'Olio FG; Toschi L; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Bearz A; Camerini A; Sala E; Migliorino MR; Cerea G; Ardizzoni A; Bennati C; Vita E; Del Conte A; Rossi S; Scotti V; Pilotto S; Cecere FL; Proto C; Berardi R; Mazzoni F; et alii...

Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy. in Advances in therapy / Adv Ther. 2020 Jul;37(7):3178-3184. doi: 10.1007/s12325-020-01386-y. Epub 2020 May 20.

2020
AO Ordine Mauriziano

Canale ML; Camerini A; Casolo G; Lilli A; Bisceglia I; Parrini I; Lestuzzi C; Del Meglio J; Puccetti C; Camerini L; Amoroso D; Maurea N;

Cardiovascular Risk Factors and Timing of Anthracyclines and Trastuzumab Cardiac Toxicity. in Anticancer research / Anticancer Res. 2019 Oct;39(10):5741-5745. doi: 10.21873/anticanres.13775.

2019
AO Ordine Mauriziano

Canale ML; Camerini A; Huqi A; Lilli A; Bisceglia I; Parrini I; Lestuzzi C; Del Meglio J; Donati S; Venturini E; Sgambato A; Tarantini L; Amoroso D; Casolo G;